0000899243-23-016382.txt : 20230623
0000899243-23-016382.hdr.sgml : 20230623
20230623165344
ACCESSION NUMBER: 0000899243-23-016382
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230621
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EVNIN LUKE
CENTRAL INDEX KEY: 0001134657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40366
FILM NUMBER: 231038481
MAIL ADDRESS:
STREET 1: THE JOHN HANCOCK TOWER
STREET 2: 200 CLARENDON STREET, 54TH STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Werewolf Therapeutics, Inc.
CENTRAL INDEX KEY: 0001785530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823523180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TALCOTT AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-952-0555
MAIL ADDRESS:
STREET 1: 200 TALCOTT AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-21
0
0001785530
Werewolf Therapeutics, Inc.
HOWL
0001134657
EVNIN LUKE
C/O MPM CAPITAL
450 KENDALL STREET
CAMBRIDGE
MA
02142
1
0
0
0
0
Stock Option (right to buy)
2.81
2023-06-21
4
A
0
13200
0.00
A
2033-06-20
Common Stock
13200
13200
D
The option was granted on June 21, 2023. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.
/s/ Jonathan Owen, Attorney-in-fact
2023-06-23